Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Globus Medical: Q4 Revenue Tops Forecast


Medical technologies specialist Globus Medical (NYSE:GMED) reported impressive results for the fourth quarter of 2024 on Thursday, Feb. 20. The highlights included adjusted earnings per share (EPS) of $0.84, exceeding the consensus forecast of $0.75, along with revenue that reached $657.3 million, topping expectations by $12.3 million.

Globus Medical's results underscore a strong quarter, with effective execution of strategic initiatives, notably the full integration of the September 2023 NuVasive merger.

Source: Globus Medical. Note: Analysts' consensus estimates for the quarter provided by FactSet. YOY = Year over year. EBITDA = Earnings before interest, taxes, depreciation, and amortization.

Continue reading


Source Fool.com

Like: 0
Share

Comments